Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s robotic systems are FDA-cleared and CE-marked for endovascular coronary and peripheral vascular interventions. Clinical results highlight improved precision in device placement, reduced radiation exposure to physicians, and potential for better clinical outcomes compared to manual procedures.
The technology enables remote-controlled manipulation of guidewires/catheters from a protected cockpit.
No drug or biologic clinical trials; focus on device-based procedural improvement.
Pipeline breadth reflects product iterations rather than traditional drug development stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Corindus Vascular Robotics.